Evaluation of short-term consequences of atrial septal defect closure in adults referred to Shahid Chamran heart center in Isfahan
- PMID: 39717425
- PMCID: PMC11663284
- DOI: 10.48305/arya.2024.31245
Evaluation of short-term consequences of atrial septal defect closure in adults referred to Shahid Chamran heart center in Isfahan
Abstract
Background: Secundum Atrial Septal Defects (ASDs) are the most common type of atrial septal defects. Today, using different types of occluders, transcatheter closure is widely used to treat ASD and has replaced the surgical procedure in anatomically suitable patients. This study was performed to evaluate the short-term clinical outcomes of treatment of adult patients requiring an ASD device closure referred to Shahid Chamran Cardiovascular Center in Isfahan, Iran.
Methods: All patients who underwent ASD treatment using transcatheter closure at Shahid Chamran Cardiovascular Center in 2020 and 2021 were recruited in this retrospective descriptive study. The characteristics of the treated lesion and the cardiovascular complications during treatment were recorded immediately and one month after treatment.
Results: A total of 70 patients (47 females and 23 males) with a mean age of 39.81±12.56 years were investigated in this study. The number of difficult anomalies was 46 (65.7%), and the most common type was the deficient aortic rim. In terms of the incidence of vascular complications, hematoma, bleeding, and pseudoaneurysm were observed in 8 patients. The most common cardiac complication was atrial fibrillation, which occurred in 12 patients. No cardiovascular complications were observed during the one-month follow-up.
Conclusion: The results of this single-institute study showed that ASD treatment by the transcatheter procedure using an ASO device at Shahid Chamran Cardiovascular Center was performed safely and successfully with very few complications. The short-term analysis of the outcomes indicated no major complications, deaths, or device malposition.
Keywords: ASD Devices; Atrial Septal Defect; Complications; Transcatheter Closure.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Transcatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results.Egypt Heart J. 2022 Aug 13;74(1):59. doi: 10.1186/s43044-022-00298-2. Egypt Heart J. 2022. PMID: 35962873 Free PMC article.
-
[Transcatheter closure of secundum atrial septal defect in children].Zhonghua Er Ke Za Zhi. 2004 Apr;42(4):287-90. Zhonghua Er Ke Za Zhi. 2004. PMID: 15157392 Clinical Trial. Chinese.
-
Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.Cureus. 2023 Jun 8;15(6):e40132. doi: 10.7759/cureus.40132. eCollection 2023 Jun. Cureus. 2023. PMID: 37425612 Free PMC article. Review.
-
Transcatheter closure of atrial septal defect with amplatzer septal occluder in adults: immediate, short, and intermediate-term results.J Tehran Heart Cent. 2011 Spring;6(2):79-84. Epub 2011 May 31. J Tehran Heart Cent. 2011. PMID: 23074610 Free PMC article.
-
Secundum atrial septal defects transcatheter closure versus surgery in adulthood: a 2000-2020 systematic review and meta-analysis of intrahospital outcomes.Cardiol Young. 2021 Apr;31(4):541-546. doi: 10.1017/S1047951121001232. Epub 2021 Apr 8. Cardiol Young. 2021. PMID: 33827735
References
-
- Abdi S, Kiani R, Momtahen M, Basiri HA, Maadani M, Abdolrahimi S, et al. Percutaneous device closure for secundum-type atrial septal defect: short and intermediate-term results. Arch Iran Med. 2012 Nov;15(11):693–5. - PubMed
-
- Cowley CG, Lloyd TR, Bove EL, Gaffney D, Dietrich M, Rocchini AP. Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am J Cardiol. 2001 Sep;88(5):589–91. - PubMed
LinkOut - more resources
Full Text Sources